← Leaderboards
Hyungsoo Kim
Sanford Burnham Prebys Medical Discovery Institute
$704,429
Attributed
$942,320
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $263.1K · FY2015–22$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$942,320 · 2
By mechanism
R21$942,320 · 2
Top collaborators
- Amanda Ellen Ramer-Tait2 shared
Most similar at Sanford Burnham Prebys Medical Discovery Institute
Same institution · by research overlap
- Lars Bode$5,602,006
Others in their field
Top investigators on “Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$206,517,726
- Richard L Schilsky · University Of Chicago$108,377,382
- Larry Arthur$59,113,709
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
- Meenhard Herlyn · University Of Pennsylvania$46,448,742
Research focus
MelanomaCellsBaseTumorNeoplastic CellMediatingReportingTreatment EfficacyTargeted TreatmentTumor GrowthResponseAttenuatedMouse ModelCheckpoint TherapyBacteroides ThetaiotaomicronAnti-Tumor Immune ResponseBacteroides FragilisBacteroidesAnti-Pd1 TherapyAnti-Ctla4Cell DeathCd8b1 GeneCell LineAttenuation
Grant awards (4)
Multi-strain, live biotherapeutics as adjuncts to checkpoint inhibitor therapy$212,696
R21 · FY2022 · CA · contact PI
Multi-strain, live biotherapeutics as adjuncts to checkpoint inhibitor therapy$263,086
R21 · FY2021 · CA · contact PI
RNF125 controls melanoma response to B-RAF inhibitor and immune checkpoint therapy$212,063
R21 · FY2016 · CA · contact PI
RNF125 controls melanoma response to B-RAF inhibitor and immune checkpoint therapy$254,475
R21 · FY2015 · CA · contact PI